| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Historical Data Period | 2019 - 2023 |
| Market Size (2025) | USD 605.82 Million |
| Market Size (2030) | USD 799.32 Million |
| CAGR (2025 - 2030) | 5.70 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
Canada Contraceptive Devices Market Analysis
The Canada Contraceptive Devices Market size is estimated at USD 605.82 million in 2025, and is expected to reach USD 799.32 million by 2030, at a CAGR of 5.7% during the forecast period (2025-2030).
Due to COVID-19-related lockdowns, access to contraception was disrupted, leading to an increase in unsafe abortions, miscarriages, pregnancy problems, HIV transmission, and other STDs, as well as an increase in PTSD, despair, suicide, and intimate partner violence. These implications disproportionately affected marginalized communities in the United States and emerging nations, widening both domestic and global healthcare inequities. As per an NCBI article published in October 2020, the COVID-19 crisis is expected to result in 7 million unwanted births for more than 47 million women, according to research by the UN agency for sexual and reproductive health (UNFPA). According to another article published in July 2022, contraceptives are limited and expensive, particularly for people living in rural and underprivileged communities. In Canada, between 30-40% of pregnancies are unplanned. Thus, the increase in unwanted and unplanned pregnancies in the country is expected to increase the complications related to childbirth in women. That is expected to drive awareness of the usage of contraceptive devices, boosting the growth of the market.
According to the Government of Canada, data published in February 2022 showed that sexually transmitted infections (STI) were a significant and ever-increasing public health concern in the country. STIs are among the most common communicable infections affecting the health and lives of people worldwide. According to the Public Health Agency of Canada (PHAC) and the Canadian AIDS Treatment Information Exchange, data published in 2022 showed that the three reportable bacterial STIs in Canada are chlamydia, gonorrhea, and infectious syphilis. Chlamydia is the most common, followed by gonorrhea and syphilis. To avoid such diseases and their transmission, contraceptive devices are recommended, which is expected to drive market growth in the country.
A rise in the number of gynecologists favoring these contraceptive methods for birth control is anticipated to drive industry growth in the coming years. The increased use of safe and effective oral tablets increased awareness of modern contraceptives, and health issues associated with teen pregnancies contribute to the market's growth. Rising awareness in the Canadian population regarding contraception methods, investments by key players to develop innovative devices, and favorable government initiatives to improve access to products are the major factors accelerating the growth. The expansion of the Canadian market for testing for STIs is expected to be driven by an increase in STD cases among the population. Rising government initiatives to introduce new diagnostic kits and tests are expected to fuel market expansion. According to PHAC reports, syphilis cases increased to 9,126 in 2020. Thus, the increasing number of STIs and other infections promotes the usage of contraceptive devices and increases their demand, thereby expecting increased market growth.
However, the side effects of contraceptive devices have been restraining the market's growth.
Canada Contraceptive Devices Market Trends
Condoms are Expected to Dominate the Canada Contraceptive Devices Market
A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or an STI. There are both male and female condoms. Women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS. They also protect against genital herpes, human papillomavirus (HPV), and syphilis to a lesser extent.
In Canada, the use of condoms has significantly increased among adolescents due to easy availability and convenience. According to the survey conducted and published in NCBI in February 2020, about 30% of the studied adult population claimed to have used a condom whenever they had intercourse. Thus, effective protection from STIs and high demand from the young population to enhance their sexual experience are expected to aid the demand for the product.
Also, increasing product launches are expected to contribute to the growth of the market during the forecast period. In May 2022, Dubbed Jems launched Vegan Condoms for safer intercourse, renouncing toxicity in all forms.
Thus, the above-mentioned factors are expected to drive the growth of the segment during the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
Vaginal Ring is Expected to Hold a Significant Share Over the Forecast Period
The vaginal ring is a small, flexible ring worn inside the vagina for birth hormones. It releases the hormones estrogen and progestin through the vaginal lining to prevent pregnancy. It is worn for three weeks and then removed for one week.
The increasing rate of unwanted pregnancies, rising awareness among the Canadian population, and increasing product launches by various market players are expected to contribute to the growth of the market.
For instance, the Impactethics article published in June 2021 mentioned that one in five Canadian women had an unintended pregnancy; over 61% of Canadian women have unintended pregnancies. Such a high incidence rate of untended pregnancies among Canadian women is expected to drive the demand for vaginal rings, thereby fueling the growth of the segment.
Increasing product launches are also expected to contribute to the growth of the market. For instance, in February 2022, Mithra and Searchlight Pharma commercially launched Mithra's vaginal contraceptive ring, Myring, under the brand name Haloette in Canada. Haloette is an affordable option for women; it was approved by Health Canada in September 2021.
Thus, the prevalence of unintended pregnancies and frequent product launches are expected to contribute to the growth of the segment.
Get Analysis on Important Geographic Markets
Download PDF
Canada Contraceptive Devices Industry Overview
The market is moderately competitive in nature. The competitive landscape includes an analysis of a few international and local companies that are well-known and hold significant market shares. Some of the key industry contributors are AbbVie Inc. (Allergan), Bayer Healthcare, Cooper Surgical Inc., and Mylan Laboratories, among others.
Canada Contraceptive Devices Market Leaders
-
Cooper Surgical Inc.
-
AbbVie Inc. (Allergan)
-
Pfizer Inc.
-
Bayer AG
-
Reckitt Benckiser
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
Canada Contraceptive Devices Market News
- May 2022: Dubbed Jems launched Vegan Condoms for safer intercourse, renouncing toxicity in all forms.
- February 2022: Mitra and Searchlight Pharma commercially launched Mithra's vaginal conceptive ring, Myring, under the brand Haloette in Canada.
Canada Contraceptive Devices Industry Segmentation
Contraceptive devices are barriers that attempt to prevent pregnancy by physically preventing sperm from entering the uterus. Contraception, more commonly known as birth control, is described as the method used to avoid pregnancy. It includes male condoms, female condoms, cervical caps, diaphragms, and contraceptive sponges with spermicide.
The Canadian contraceptive devices market is segmented by type (condoms, diaphragms, cervical caps, sponges, vaginal rings, intrauterine devices (IUDs), and other types) and gender (male and female). The report offers the value (in USD million) for the above segments.
| By Type | Condoms |
| Diaphragms | |
| Cervical Caps | |
| Sponges | |
| Vaginal Rings | |
| Intra Uterine Device (IUDs) | |
| Other Types | |
| By Gender | Male |
| Female |
Need A Different Region or Segment?
Customize Now
Canada Contraceptive Devices Market Research FAQs
How big is the Canada Contraceptive Devices Market?
The Canada Contraceptive Devices Market size is expected to reach USD 605.82 million in 2025 and grow at a CAGR of 5.70% to reach USD 799.32 million by 2030.
What is the current Canada Contraceptive Devices Market size?
In 2025, the Canada Contraceptive Devices Market size is expected to reach USD 605.82 million.
Who are the key players in Canada Contraceptive Devices Market?
Cooper Surgical Inc., AbbVie Inc. (Allergan), Pfizer Inc., Bayer AG and Reckitt Benckiser are the major companies operating in the Canada Contraceptive Devices Market.
What years does this Canada Contraceptive Devices Market cover, and what was the market size in 2024?
In 2024, the Canada Contraceptive Devices Market size was estimated at USD 571.29 million. The report covers the Canada Contraceptive Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Canada Contraceptive Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Canada Contraceptive Equipment Industry Report
Statistics for the 2025 Canada Contraceptive Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Canada Contraceptive Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
